LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

Inicio・Lista de Acciones・Abbott Laboratories

Abbott Laboratories

Cerrado

Sector Salud

117.98 0.19

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

117.17

Máximo

118.54

Métricas clave
By Trading Economics
Ingresos	77M 1.3B
Ventas	220M 11B
P/B Media del Sector	32.37 112.16
BPA	1.21
Margen de beneficio	12.543
Empleados	114,000
EBITDA	170M 2.6B

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 meses	+11.29 upside

Dividendos
By Dow Jones
Fecha Próximo Dividendo	15 nov 2024
Próxima Fecha de Ex Dividendo	9 ene 2025

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	7.2B 204B
Apertura anterior	117.79
Cierre anterior	117.98

Noticias sobre sentimiento de mercado

By Acuity

33%

67%

95 / 366 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Very Strong Bullish Evidence

115.95 / 118.36 Soporte y Resistencia

Abbott Laboratories Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

16 oct 2024, 12:03 UTC

Ganancias

Abbott Laboratories 3Q Sales Top Expectations

29 jul 2024, 10:30 UTC

Principales Movimientos del Mercado

Abbott Laboratories Shares Tumble on $495 Million Infant Formula Verdict

29 jul 2024, 09:27 UTC

Principales Movimientos del Mercado

Reckitt Benckiser Shares Tumble on Abbott's Baby-Formula Litigation

18 jul 2024, 12:21 UTC

Ganancias

Abbott Labs Lifts FY24 Outlook After 2Q Sales Rise

16 oct 2024, 14:21 UTC

Principales Noticias

Ganancias

Abbott Posts Solid Quarter. The Stock Is Rising. -- Barrons.com

16 oct 2024, 12:25 UTC

Ganancias

Abbott Labs Beats Q3 Sales And Earnings Expectations, Raises Full-Year Outlook -- MarketWatch

16 oct 2024, 12:02 UTC

Principales Noticias

Ganancias

Abbott Posts Solid Quarter. That Wasn't Enough to Lift Shares. -- Barrons.com

16 oct 2024, 11:59 UTC

Ganancias

Abbott Earnings Edge Past Q3 Views, Led By Medical Devices -- IBD

16 oct 2024, 11:37 UTC

Ganancias

Abbott Labs Sees 4Q Adj EPS $1.31-Adj EPS $1.37 >ABT

16 oct 2024, 11:36 UTC

Ganancias

Abbott Labs Sees 4Q EPS 96c-EPS $1.02 >ABT

16 oct 2024, 11:35 UTC

Ganancias

Abbott Labs: Well-positioned to Achieve Upper End of Our Initial Guidance Ranges for Yr and Have Great Momentum Heading Into Next Yr >ABT

16 oct 2024, 11:35 UTC

Ganancias

Abbott Labs Maintains Full-Yr 2024 Organic Sales Growth Guidance Range of 9.5% to 10.0%, Excluding COVID-19 Testing-Related Sales >ABT

16 oct 2024, 11:30 UTC

Ganancias

Abbott Labs 3Q Organic Sales Growth Up 7.6% >ABT

16 oct 2024, 11:30 UTC

Ganancias

Abbott Labs 3Q Sales $10.64B >ABT

16 oct 2024, 11:30 UTC

Ganancias

Abbott Labs 3Q Net $1.65B >ABT

16 oct 2024, 11:30 UTC

Ganancias

Abbott Labs 3Q Adj EPS $1.21 >ABT

16 oct 2024, 11:30 UTC

Ganancias

Abbott Labs Sees FY Adj EPS $4.64-Adj EPS $4.70 >ABT

16 oct 2024, 11:30 UTC

Ganancias

Abbott Labs Sees FY EPS $3.34-EPS $3.40 >ABT

16 oct 2024, 11:30 UTC

Ganancias

Abbott Labs 3Q EPS 94c >ABT

29 jul 2024, 10:15 UTC

Principales Movimientos del Mercado

Abbott Laboratories Shares Tumble on $495 Mln Infant Formula Verdict

29 jul 2024, 08:50 UTC

Acciones populares

Stocks to Watch Monday: Coinbase, Abbott, McDonald's, Heineken -- WSJ

18 jul 2024, 19:04 UTC

Charlas de Mercado

Ganancias

Abbott CEO Warns of Health Crisis if Preterm Formula Pulled -- Market Talk

18 jul 2024, 11:43 UTC

Ganancias

Abbott Laboratories Earnings Top Views, Full-Year Guidance Raised -- IBD

18 jul 2024, 11:34 UTC

Ganancias

Abbott Labs Sees 3Q Adj EPS $1.18-Adj EPS $1.22 >ABT

18 jul 2024, 11:34 UTC

Ganancias

Abbott Labs Sees 3Q EPS 85c-EPS 89c >ABT

18 jul 2024, 11:31 UTC

Ganancias

Abbott Labs Narrows FY24 Organic Sales Growth View, Ex-COVID-19 Testing-Related Sales, to 9.5% to 10% >ABT

18 jul 2024, 11:30 UTC

Ganancias

Abbott Labs Sees FY Adj EPS $4.61-Adj EPS $4.71 >ABT

18 jul 2024, 11:30 UTC

Ganancias

Abbott Labs Sees FY EPS $3.30-EPS $3.40 >ABT

18 jul 2024, 11:30 UTC

Ganancias

Abbott Labs 2Q Organic Sales Growth Up 7.4% >ABT

18 jul 2024, 11:30 UTC

Ganancias

Abbott Labs 2Q Sales $10.38B >ABT

Comparación entre iguales

Cambio de precio

Abbott Laboratories Esperado

Precio Objetivo

By TipRanks

11.29% repunte

Estimación a 12 meses

Media 131.12 USD 11.29%

Máximo 143 USD

Mínimo 107 USD

De acuerdo con 19 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Abbott Laboratories Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

19 ratings

Comprar

Mantener

Vender

De acuerdo con 19 analistas que ofrecen calificaciones bursátiles a para Abbott Laboratories Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

115.95 / 118.36Soporte y Resistencia

Recent bullish events outweigh bearish events.

Bullish events outweigh bearish events.

Sentimiento

By Acuity

95 / 366 Clasificación en Salud

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Abbott Laboratories

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.